제7회 서울국제신약포럼 > Forum & Conference

본문 바로가기

파이낸셜뉴스 부산파이낸셜뉴스 블록포스트 가이드포스트 fn아이포커스 파이낸셜뉴스재팬 fnMICE fn이노에듀 fn투어


지난행사목록

본문

 

Andrew J. Peat
Senior Director/GSK

Andrew Peat received his BSc in 1992 from Miami University and his PhD from MIT in 1997 under the direction of Professor Stephen Buchwald. Andy’s research involved the development and application of transition metal (Pd, Zr) chemistry towards heterocyclic ring construction and alkaloid natural products. After joining Glaxo Wellcome, Research Triangle Park NC, in 1997, Andy worked in the area of metabolic diseases and contributed to the development of two clinical assets. He was promoted to a section leader in 2008 and began pursuing therapies within Infectious Diseases, one of which entered clinical development. Shortly thereafter, Andy served as the leader of the HCV polymerase program and is a co-inventor of GSK175 which is in Phase 2 clinical trials. He is currently the head of the Host Defense Chemistry & DMPK department and the Clinical Development Leader of a novel anti-inflammatory agent in Phase 2 clinical trials.
Andy has held a number of positions within GSK which include leading an external chemistry outsourcing initiative and developing in silico chemistry design tools. He also created within GSK a Chemistry Performance Unit that is exploring and expanding the utility of atypical elements in drug discovery. He is a member of the Long-Range Planning Committee of the MEDI division within the American Chemical Society and has chaired symposia at national ACS events. In addition to numerous external presentations, Andy is a primary author of 30 peer-reviewed publications and 15 patents.
 
 
John Watson
Executive Director/Research Technology Management, Institut Pasteur Korea.

Employment /Career Experiences 

Institut Pasteur Korea, Panygo, Gyeonggi, Korea (01/2015 – present) 
Executive Director (본부장), Research Technology Management
Management of all Business Development functions including drug compound licensing, intellectual property processes, and collaboration agreements.
Reorganized communications team, reviewed and implemented new BD processes.

Promega, USA (2005 - 12/2014)
Global Director of Marketing _ Director of Cellular AnalysisP&L responsibility for the Cellular Analysis/Drug Screening business unit at Promega. Took the Cellular Analysis business unit from less $9,000,000 to over $100,000,000 through organic growth. Established new applied market product lines for biologics, environmental testing, and food safety.

Thermo, USA (05/2003-/2005)
Director, FTIR Business Unit

Education
B.S. Genetics and Cell Biology, University of Minnesota(1980-1985)
M.S. Bacteriology, University of Wisconsin(1988-1989)
Ph.D. Biomolecular Chemistry, University of Wisconsin(1988-1993)
 
 
Shin, Eui-Cheol 
Associate Professor/Graduate School of Medical Science & Engineering, KAIST

EDUCATION:
1990-1996: M.D., graduated in 1st in class,
Yonsei University College of Medicine, Seoul, Korea
1996-2001: Ph.D. (in Microbiology & Immunology),
Yonsei University College of Medicine, Seoul, Korea

CAREER:
1996-1999: Teaching Assistant, Department of Microbiology,
Yonsei University College of Medicine, Seoul, Korea
1999-2002: Medical Scientist, Department of Microbiology,
The Armed Forces Medical Research Institute, Daejeon, Korea,
(Mandatory military service)
2002-2007: Research Fellow, Immunology Section, Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD, USA
(Advisor: Barbara Rehermann, M.D.)
2007-present: Assistant Professor, Associate Professor
Graduate School of Medical Science and Engineering,
KAIST, Daejeon, Korea
 
 
Cem Ozesen
Executive Medical Director/Korea – MSD

EDUCATION: Primary school: TED Ankara College
(1967 - 1972; graduation with honours)
Secondary school: TED Ankara College
(1972 - 1975; graduation with honours)
High school: TED Ankara College
(1975 - 1978; graduation with honours)
University: University of Istanbul, Istanbul Faculty of Medicine
(1978 – 1984; graduation with honours)

MILITARY AND OBLIGATORY SERVICE:
None pending. Military service acc. in 1988 (June - August).
Obligatory medical service acc.(January 1985 - January 1987)

CAREER RECORD: - Staff GP - Kayseri SSK Hospital
(January 1985 - August 1987)
- Staff GP - Bakirköy SSK Hospital
(August 1987 - December 1987)
- Associate Medical Director - FAKO Pharm.
(January 1988 - January 1991)
- Medical Director – FAKO Pharm.
(January 1991 - August 1998)
- Clinical Research Manager- PFIZER
(October 1998 – June 2000)
- Unasyn-Sulperazon Wordwide Medical Manager-
PFIZER (June 2000 – December 2000)
- Cofounder & President - ARES CRO Services
(December 2000 – September 2007)
- Cofounder & President – AresKare Medical
Advertising Agency
(December 2004 – September 2007)
- Clinical Research Manager – MSD Turkey
(September 2007 – February 2010)
- Middle East and Africa GCTO Lead – MSD
(February 2010 – March 2011)
- Research Director, Middle East and Africa - MSD
(April 2011 – May 2012)
- Medical Director, Africa - MSD
(October 2011 – October 2013)
- Medical Director, Korea – MSD
(November 2013 – ongoing)
 
 
Im, Weon-Bin
Director, Team Leader/Dong-A ST

Education
2011 Ph.D. in Medicinal Chemistry, Ajou University, Suwon, Korea
1990 M.A. in Chemistry, Sogang University, Seoul, Korea
1988 B.S. in Chemistry, Sogang University, Seoul, Korea 

Experience
2013 ~ current Dong-A ST 
-Director, Team Leader
1990 ~ 2012 Dong-A pharmaceutical co., Ltd 
-Sr. Scientist
-Team Leader
 
 
Song, Jin-Won
Vice President/Medical Research & Academic Affairs, Korea University, Seoul, Korea

Education 
1987 M.D., Korea University, College of Medicine, Seoul, Korea
1989 M.S., Korea University Graduate School,, Seoul, Korea
1994 Ph.D., Korea University Graduate School, Seoul, Korea (Microbiology)

Professional History
1993-1997 Visiting Fellow, National Institutes of Health, Bethesda, Maryland, U.S.A.
1996-present Professor, Department of Microbiology, College of Medicine, Korea University, Seoul 136-705, Korea
2005-2006. Visiting Scholar, John A. Burns School of Medicine, University of Hawaii at Manoa , Honolulu HI, U.S.A. 
2008.- 2010. Vice Dean for General affairs, College of Medicine, Korea University, Seoul, Korea
2007- 2011 Director, the Institute for Viral Diseases, Korea University, Seoul, Korea 
2008.- present Director on the Board, the Korea Support Committee for International Vaccine Institute (IVI)
2011.- present Director, the Institute of Biomedical Science & Food Safety, Korea University, Seoul, Korea
2012.-present Vice President for Medical Research & Academic Affairs, Korea University, Seoul, Korea

Honors and Awards 

1998 2nd Hantaan Prize, The Hantaan Life Science Foundation, Seoul, Korea
2011 56th the National Academy of Sciences Award, Korea National Academy of Sciences, Seoul, Korea
2013 1st Ho Wang Lee Award, International Hantavirus Society, XI International Conference on HFRS HPS & Hantavirus, Beijing, China.
 
 
Jee, Young-Mee 
Director/Center for Pathology and Immunology, Korea Centers for Disease Control & Prevention

Education 
Ph.D. in Virology
University of London (Faculty of Medicine), 1997, United Kingdom
Thesis title: The Properties of Hepatitis B Virus Envelope Proteins and Their Interactions with Cultured Cells 

Diploma in Medical Microbiology
London School of Hygiene and Tropical Medicine
University of London, 1988, United Kingdom
Thesis title: A Review of Studies in Faecal Mutagens in Large Bowel Cancer 

Medical Degree 
College of Medicine,
Seoul National University, 1986, Seoul, Korea

Qualification
Licensed for Medical Practice in Korea, Feb. 1986 (License No. 30376) 

Employment
From To Institute/Organization
Oct 2014-present Director, Center for Pathology and Immunology, 
National Institute of Health
Korea Centers for Disease Control & Prevention

Aug 2007-Oct 2014 Expanded Programme on Immunization (EPI), 
Division of Combating Communicable Disease Control 
Western Pacific Regional Office, World Health Organization

Oct. 2006 - Nov. 2006 Short term Consultant in EPI/WPRO 

Dec 2003- August 2007 Head, Division of Enteric and Hepatitis Viruses
Center for Infectious Diseases 
National Institute of Health
Korea Centers for Disease Control & Prevention 

Nov. 2000 - Dec. 2000 Short term Consultant in EPI/WPRO 

Jul. 1997– Dec. 2003 Senior Researcher, Laboratory of Enteroviruses, 
Department of Virology, National Institute of Health, Seoul Korea

Mar. 1998 – Feb. 2001 Invited full-time lecturer in College of Medicine, Seoul National University 

1986 -1987 Guest Scientist, Laboratory of Molecular Carcinogenesis,
National Cancer Institute, National Institute of Health, U.S.A
 
 
Lee, Seong-Geong
Director/Korea Research Institute of Chemical Technology 

Education
1980 – 1984: BS, Pharmaceutical Department,, Seoul National University
1992 – 1998: Ph. D. Department of Medicinal Chemistry and Pharmacology Purdue University, USA

Employment
1984 – 1987 CJ
1988 – 1990 Korea Research Institute of Chemical Technology, Researcher
1999 - 2004 Korea Research Institute of Chemical Technology, Senior Researcher
2005 – present Korea Research Institute of Chemical Technology Principal Researcher
2014 – present Korea Research Institute of Chemical Technology Bio and Drug Discovery Division, Director

Main Research Area: Medicinal Chemistry Anticancer, Cardiovascular drug, Immune related disease
 
 
Lee, Jin-Gyu
Director-General/Ministry of Science, ICT and Future Planning

 
 
Ahn, Dong-Ho 
Vice President/Central Research Center, Green Cross Corp

EDUCATION:

1989-1993 
PhD 
Field: Applied Microbiology
Korea Advanced Institute of Science and Technology 
Dissertation: Domain Structure and Proteolysis of Bacillus subtilus Endo-β-1,4-glucanase

1983-1985 
M.S.
Field: Applied Microbiology
Korea Advanced Institute of Science and Technology
Dissertation: Molecular Cloning and Expression of Bacillus subtilus Endo-β-1,4-glucanase Gene in Escherichia coli

1978-1982 
B.S. 
Field: Agricultural Chemistry
Seoul National University 

PRINCIPAL POSITIONS HELD:

1985-2005 Senior Scientist, 
Responsible for the development vaccines and recombinant protein drugs
CJ cheiljedang Corp.

2006-2008 Vice President, Responsible for the development of DNA vaccines and Fc-fused protein drugs, Genexine Corp.
2008-Current Vice President, Head of Vaccine Process Development Unit, Responsible for the development vaccines against infectious diseases, Central Research Center, Green Cross Corp.
 
 
Yong, Dong-Eun
Professor/Department of Laboratory Medicine Yonsei University College of Medicine

Education and Appointment

1992.2 Yonsei University College of Medicine (YUMC)
2000.2 Specialist Board in Laboratory Medicine, Korean Ministry of Health and Welfare
2002.9 Korea University Medicine College (Ph.D.)
2000.3-2003.8 Instructor of Laboratory Medicine at YUMC
2004.9-2007.2 Assistant Professor
Dept. of Laboratory Medicine, YUMC
2007.3-2013.2 Associate Professor
Dept. of Laboratory Medicine, YUMC
2006.9-2008.8 Postdoc. Research Fellow, Cardiff University, UK.
2000.3-present Researcher at Research Institute of Bacterial Resistance
2013.3-present Professor
Dept. of Laboratory Medicine, YUMC
 
 

첨부파일

서울특별시 서초구 강남대로 315, 파이낸셜뉴스빌딩 9층 | TEL. 02-6965-0016 | FAX. 02-6965-0000 | E-mail : info@fnmice.com
Copyright (c) fnMICE. All rights reserved.